Current Report Filing (8-k)
April 13 2017 - 5:29PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):
April 7,
2017
DTHERA
SCIENCES
(Exact Name of Registrant as Specified in
Charter)
Nevada
|
333-191175
|
90-0925768
|
(State or Other Jurisdiction of Incorporation)
|
Commission File Number
|
(IRS Employer Identification No.)
|
7310 Miramar Rd., San Diego, CA
|
92126
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code:
(858)
215-6360
(Former name or former address, if changed
since last report.)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[_] Written communications pursuant to
Rule 425 under the Securities Act
[_] Soliciting material pursuant to
Rule 14a-12 under the Exchange Act
[_] Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act
|
ITEM 4.02
|
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed
Interim Review
|
On April 7, 2017, the Board of Directors
of Dthera Sciences (the “Company”), functioning as the Company’s Audit Committee, determined that certain of
the Company’s previously filed financial statements can no longer be relied upon. While preparing the Annual Report on Form
10-K for the fiscal year ended December 31, 2016, the Company’s management became aware of an issue affecting the Company’s
previously filed financial statements, described in more detail below. Accordingly, the Company’s management, in conjunction
with the Board of Directors, has determined that the Company’s financial statements in its transitional quarterly report
on Form 10-Q for the period ended September 30, 2016, should no longer be relied upon.
The purpose of this Amendment on Form 10-Q
for the nine months ended September 30, 2016, filed with the Securities and Exchange Commission on November 21, 2016, is to remove
the conversion of 4,146,993 options that were accounted for as common stock during the share exchange transaction between the Company
and EveryStory, Inc.,, to correct the stockholders equity to properly reflect stock issuances, and to record the amortization of
options.
The Company’s management has discussed
the revisions and corrections discussed above with the Company’s independent public accounting firm, and believes that the
issues are related to and arose in connection with the share exchange transaction between the Company (f/k/a Knowledge Machine
International, Inc.) and EveryStory, specifically a misinterpretation relating to the derivative securities of EveryStory and their
treatment under the share exchange agreement. Because that transaction has been concluded, management does not believe that any
continuing errors will result, although management will continue to review the financial statements and components of the share
exchange transaction to determine if any other misinterpretations have occurred.
The Board of Directors has discussed the
issues described above with the Company’s current independent registered public accounting firm, Sadler Gibb & Associates,
LLC (“SG”), as well as the effectiveness of the Company’s disclosure controls and procedures and internal controls
over financial reporting, and the determination that the above-referenced financial statements should no longer be relied upon.
The Company has provided to SG a copy of this Current Report
on Form 8-K and the disclosures made in response to Item 4.02 above, for their review and comment. The Company has requested SG
to provide a letter addressed to the Commission stating whether or not it agrees with the statements and disclosures provided
herein with regard to SG and, if not, stating the respects in which SG does not agree.
|
ITEM 9.01
|
Financial Statements and Exhibits
|
(d) Exhibits
|
Exhibit No.
|
Description
|
|
|
|
|
16.1
|
Letter from SG (to be filed by amendment)
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Dthera Sciences
|
|
|
Date: April 13, 2017
|
By:
|
/s/ Edward Cox
|
|
Name:
Title:
|
Edward Cox
Chief Executive Officer
|
Dthera Sciences (GM) (USOTC:DTHR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Dthera Sciences (GM) (USOTC:DTHR)
Historical Stock Chart
From Jul 2023 to Jul 2024